Sera Prognostics Inc., The Pregnancy Company® , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that ...

The Kooyong Classic has welcomed tennis legend and former Wimbledon champion Pat Cash as an official ambassador for the ...

If approved in SM, it will compete with established targeted therapies Novartis’ Rydapt (midostaurin ... It is chasing after Vertex Pharma’s VX-548, which also targets NaV1.8 and last month ...

The financing was led by TCGX and included TPG, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital, and Logos Capital ... applications across the pharma, food, and chemical ...

Novartis was announced as an official partner of this year’s Eurovision competition last fall, after the song entry from ...

To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as ...

The Swiss pharma giant – which has its U.S. headquarters in East Hanover – said it aims to encourage football fans to "proactively manage their health." ...

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

Novartis (NVS) announced that oral Fabhalta, iptacopan, has received U.S. Food and Drug Administration approval for the ...

Novartis’s (NVS) parasite-selective proteasome inhibitor with potent activity against kinetoplastid parasites was granted FDA orphan ...

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

The National Football League (NFL) announced Novartis as its first-ever corporate pharmaceutical partner on March 13.